Crown Bioscience Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
700
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$204M
Crown Bioscience General Information
Description
Operator of a biology contract research organization intended to offer discovery and early development provisions. The company offers integrated pre-clinical oncology and protein science platform services, including molecular biology or cloning, protein expression and purification, protein assay, structural biology, process development and antibodies, enabling biotech and pharmaceutical businesses internationally to accelerate their new drug development programs.
Contact Information
Website
www.crownbio.com(Operating Subsidiary)
Corporate Office
- 16550 West Bernardo Drive
- Building 5, Suite 525
- San Diego, CA 92127
- United States
Corporate Office
- 16550 West Bernardo Drive
- Building 5, Suite 525
- San Diego, CA 92127
- United States
Crown Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 13-Nov-2025 | $204M | Completed | Generating Revenue | ||
| 8. Merger/Acquisition | 28-Jun-2018 | Completed | Generating Revenue | |||
| 7. IPO | 18-Feb-2016 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 15-May-2014 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 24-Jul-2013 | Completed | Startup | |||
| 4. Later Stage VC (Series C) | 01-Apr-2011 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 17-Jul-2008 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 20-Apr-2007 | $3.06M | $3.07M | Completed | Startup | |
| 1. Angel (individual) | 20-Oct-2006 | $10.5K | $10.5K | Completed | Startup |
Crown Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 24,487,982 | 8% | $0.12 | $0.12 | 1x | $0.12 | 16.04% |
Crown Bioscience Comparisons
Industry
Financing
Details
Crown Bioscience Competitors (9)
One of Crown Bioscience’s 9 competitors is BPS Bioscience, a Corporation company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Sygnature Discovery | Private Equity-Backed | Nottingham, United Kingdom | ||||
| Neurocrine Biosciences | Formerly VC-backed | San Diego, CA | ||||
| Esperion Therapeutics | Private Equity-Backed | Ann Arbor, MI | ||||
| Sanescohealth | Corporation | Asheville, NC |
Crown Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Crown Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Crown Bioscience Former Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Acorn Campus Ventures | Venture Capital | Minority | ||
| Acorn Pacific Ventures | Venture Capital | Minority | ||
| CDIB Capital International | PE/Buyout | Minority | ||
| Chemizon | Corporation | Minority | ||
| China Renaissance Capital Investment | Venture Capital | Minority |
Crown Bioscience Investments & Acquisitions (8)
Crown Bioscience’s most recent deal was a Merger/Acquisition with Indivumed Services for . The deal was made on 31-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Indivumed Services | 31-Mar-2023 | Merger/Acquisition | Drug Discovery | ||
| OcellO | 05-May-2021 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Gallo Merger Sub | 01-Jun-2018 | Merger/Acquisition | Holding Companies | ||
| PreClinOmics | 08-Mar-2016 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Molecular Response (PDX business unit) | 12-Feb-2015 | Merger/Acquisition | Drug Discovery |
Crown Bioscience Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Crown Bioscience North Carolina | Kannapolis, NC | 2012 | |
| Indivumed Services | Hamburg, Germany | 2002 |
Crown Bioscience FAQs
-
When was Crown Bioscience founded?
Crown Bioscience was founded in 2006.
-
Where is Crown Bioscience headquartered?
Crown Bioscience is headquartered in San Diego, CA.
-
What is the size of Crown Bioscience?
Crown Bioscience has 700 total employees.
-
What industry is Crown Bioscience in?
Crown Bioscience’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Crown Bioscience a private or public company?
Crown Bioscience is a Private company.
-
What is the current valuation of Crown Bioscience?
The current valuation of Crown Bioscience is .
-
What is Crown Bioscience’s current revenue?
The current revenue for Crown Bioscience is .
-
How much funding has Crown Bioscience raised over time?
Crown Bioscience has raised $108M.
-
Who are Crown Bioscience’s investors?
Acorn Campus Ventures, Acorn Pacific Ventures, CDIB Capital International, Chemizon, and China Renaissance Capital Investment are 5 of 15 investors who have invested in Crown Bioscience.
-
Who are Crown Bioscience’s competitors?
BPS Bioscience, Sygnature Discovery, Neurocrine Biosciences, Esperion Therapeutics, and Sanescohealth are some of the 9 competitors of Crown Bioscience.
-
When was Crown Bioscience acquired?
Crown Bioscience was acquired on 13-Nov-2025.
-
Who acquired Crown Bioscience?
Crown Bioscience was acquired by Adicon Clinical Laboratory.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
